Literature DB >> 18797262

Rapid resolution of dopamine dysregulation syndrome (DDS) after subthalamic DBS for Parkinson disease (PD): a case report.

David Knobel1, Selma Aybek, Claudio Pollo, François J G Vingerhoets, Alexandre Berney.   

Abstract

OBJECTIVE: To describe how subthalamic deep brain stimulation (STN-DBS) and reduction in dopamine replacement therapy (DRT) allowed rapid resolution of dopamine dysregulation syndrome (DDS) with severe behavioral disorder in a patient with late stage Parkinson disease (PD).
BACKGROUND: DDS was recently defined as compulsive use of dopaminergic drugs, associated with severe behavioral symptoms, and impaired social functioning, occurring in about 4% of PD patients under DRT. STN-DBS is an effective treatment for late stage PD with treatment resistant motor fluctuations, which frequently allows also to reduce DRT.
METHODS: A late stage PD patient referred to our center for STN-DBS, suffering from severe DDS necessitating in-ward psychiatric management, was comprehensively assessed preoperatively and postoperatively for motor, cognitive, and psychiatric status.
RESULTS: Following subthalamic DBS procedure and medication reduction, we observed a rapid and dramatic resolution of DDS and associated psychiatric symptoms, allowing discharge from a 2-year stay in a psychiatric institution.
CONCLUSIONS: DDS occurring in late stage PD patients may be dramatically improved by STN-DBS, possibly in relation with the reduction of dopaminergic medication. In contrast to other psychiatric symptoms, DDS should not be considered as an obstacle to DBS procedure in late stage PD patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18797262     DOI: 10.1097/WNN.0b013e318185e6e2

Source DB:  PubMed          Journal:  Cogn Behav Neurol        ISSN: 1543-3633            Impact factor:   1.600


  14 in total

Review 1.  Deep brain stimulation for the treatment of addiction: basic and clinical studies and potential mechanisms of action.

Authors:  R Christopher Pierce; Fair M Vassoler
Journal:  Psychopharmacology (Berl)       Date:  2013-08-02       Impact factor: 4.530

Review 2.  New pharmacological and neuromodulation approaches for impulsive-compulsive behaviors in Parkinson's disease.

Authors:  Giacomo Grassi; Giovanni Albani; Federica Terenzi; Lorenzo Razzolini; Silvia Ramat
Journal:  Neurol Sci       Date:  2021-04-14       Impact factor: 3.307

Review 3.  Deep brain stimulation for the treatment of drug addiction.

Authors:  Tony R Wang; Shayan Moosa; Robert F Dallapiazza; W Jeffrey Elias; Wendy J Lynch
Journal:  Neurosurg Focus       Date:  2018-08       Impact factor: 4.047

Review 4.  Management of impulse control disorders in Parkinson's disease: Controversies and future approaches.

Authors:  Michael Samuel; Maria Rodriguez-Oroz; Angelo Antonini; Jonathan M Brotchie; Kallol Ray Chaudhuri; Richard G Brown; Wendy R Galpern; Melissa J Nirenberg; Michael S Okun; Anthony E Lang
Journal:  Mov Disord       Date:  2015-01-21       Impact factor: 10.338

Review 5.  Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention.

Authors:  Angelo Antonini; Roberto Cilia
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

6.  Frontal cortex-like functions of the subthalamic nucleus.

Authors:  Christelle Baunez; Sylvie Lardeux
Journal:  Front Syst Neurosci       Date:  2011-10-11

7.  Dopamine dysregulation syndrome and deep brain stimulation of the subthalamic nucleus in Parkinson's disease.

Authors:  Beatriz De la Casa-Fages; Francisco Grandas
Journal:  Neurol Res Int       Date:  2011-11-02

8.  Effects of STN and GPi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome.

Authors:  Sarah J Moum; Catherine C Price; Natlada Limotai; Genko Oyama; Herbert Ward; Charles Jacobson; Kelly D Foote; Michael S Okun
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

9.  Impulsivities and Parkinson's disease: delay aversion is not worsened by Deep Brain Stimulation of the subthalamic nucleus.

Authors:  Diana M E Torta; Vincenzo Vizzari; Lorys Castelli; Maurizio Zibetti; Michele Lanotte; Leonardo Lopiano; Giuliano Geminiani
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

10.  Dopamine agonists and pathologic behaviors.

Authors:  Brendan J Kelley; Andrew P Duker; Peter Chiu
Journal:  Parkinsons Dis       Date:  2012-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.